Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

1.

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study.

Diabetes Care. 2002 Nov;25(11):1919-27.

PMID:
12401733
[PubMed - indexed for MEDLINE]
2.
3.

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.

Mann JF, Lonn EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, Bosch J, Dagenais GR, Yusuf S; HOPE Investigators.

Kidney Int. 2004 Apr;65(4):1375-80.

PMID:
15086477
[PubMed - indexed for MEDLINE]
5.

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR; HOPE and HOPE-TOO Trial Investigators.

JAMA. 2005 Mar 16;293(11):1338-47.

PMID:
15769967
[PubMed - indexed for MEDLINE]
6.

Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P.

N Engl J Med. 2000 Jan 20;342(3):154-60.

PMID:
10639540
[PubMed - indexed for MEDLINE]
Free Article
7.

The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, Yusuf S; HOPE investigators.

Diabetologia. 2005 Sep;48(9):1749-55. Epub 2005 Jul 30.

PMID:
16059716
[PubMed - indexed for MEDLINE]
8.

Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.

Gerstein HC.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S82-5. Review.

PMID:
12324991
[PubMed - indexed for MEDLINE]
9.

The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E; HOPE Investigators.

J Cardiovasc Electrophysiol. 2009 Jul;20(7):781-7. doi: 10.1111/j.1540-8167.2009.01440.x. Epub 2009 Feb 27.

PMID:
19298567
[PubMed - indexed for MEDLINE]
10.

Effect of long-term therapy with ramipril in high-risk women.

Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S; HOPE Investigators. Heart Outcomes Prevention Evaluation.

J Am Coll Cardiol. 2002 Aug 21;40(4):693-702.

PMID:
12204499
[PubMed - indexed for MEDLINE]
Free Article
11.

Diabetes and the HOPE study: implications for macrovascular and microvascular disease.

Gerstein HC.

Int J Clin Pract Suppl. 2001 Jan;(117):8-12.

PMID:
11715357
[PubMed - indexed for MEDLINE]
12.

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative Group.

Diabetes Care. 2003 Dec;26(12):3264-72.

PMID:
14633812
[PubMed - indexed for MEDLINE]
13.

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):56-65.

PMID:
15998891
[PubMed - indexed for MEDLINE]
14.

Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.

Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S; HOPE Trial Investigators.

Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):75-81.

PMID:
15703510
[PubMed - indexed for MEDLINE]
15.

What should the role of ACE inhibitors be in the treatment of diabetes? Lessons from HOPE and MICRO-HOPE.

Heinig RE.

Diabetes Obes Metab. 2002 Jan;4 Suppl 1:S19-25. Review.

PMID:
11843951
[PubMed - indexed for MEDLINE]
17.

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.

N Engl J Med. 2000 Jan 20;342(3):145-53. Erratum in: N Engl J Med 2000 Mar 9;342(10):748. 2000 May 4;342(18):1376.

PMID:
10639539
[PubMed - indexed for MEDLINE]
Free Article
18.

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group.

Diabetes Care. 2003 Oct;26(10):2713-21.

PMID:
14514569
[PubMed - indexed for MEDLINE]
19.
20.

Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE.

Lonn EM, Yusuf S, Doris CI, Sabine MJ, Dzavik V, Hutchison K, Riley WA, Tucker J, Pogue J, Taylor W.

Am J Cardiol. 1996 Oct 15;78(8):914-9.

PMID:
8888665
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk